NCT03540355View on ClinicalTrials.gov

Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment

PHASE3UnknownINTERVENTIONAL

Enrollment

312

Participants

Timeline

Start Date

January 29, 2021

Primary Completion Date

November 30, 2023

Study Completion Date

February 28, 2024

Conditions

Dyslipidemias

Interventions

DRUG

Cipros 20 association

oral, once a day

DRUG

Crestor 20 mg

Oral, once a day

Trial Locations (1)

Unknown

RECRUITING

Allergisa, Campinas

Sponsors

Lead Sponsor

All Listed Sponsors

lead

EMS

INDUSTRY

NCT03540355 - Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment | Biotech Hunter | Biotech Hunter